Ferrous Asparto + Methylcobalamin + L-Methylfolate PCD Delhi

Ferrous Asparto + Methylcobalamin + L-Methylfolate Mfg Baddi

Ferrous Asparto + Methylcobalamin + L-Methylfolate Franchise

Ferrous Asparto + Methylcobalamin + L-Methylfolate Supplier

Ferrous Asparto + Methylcobalamin + L-Methylfolate Exporter
Ferrous Asparto + Methylcobalamin + L-Methylfolate Opportunity

Home/Products /ferrous-asparto-glycinate-methylcobalamin-l-methylfolate-calcium-tablet

About the Product

Description


Hematyle Tablet is a specialized hematinic and nutritional supplement designed to support healthy red blood cell formation, correct iron deficiency, and maintain adequate levels of essential vitamins for hematopoiesis. Ferrous Asparto Glycinate is a well-absorbed, gentle form of iron that replenishes iron stores with minimal gastrointestinal irritation compared to traditional iron salts. Methylcobalamin, the active coenzyme form of vitamin B12, plays a vital role in red blood cell production, nerve function, and DNA synthesis. L-Methylfolate Calcium is the bioactive form of folic acid, bypassing the need for metabolic conversion, making it particularly effective in patients with folate metabolism issues such as MTHFR gene polymorphisms. Together, these ingredients correct nutritional deficiencies, enhance hemoglobin synthesis, and improve overall hematological health. Hematyle is especially beneficial for pregnant and lactating women, individuals with chronic anemia, nutritional deficiencies, and patients recovering from illness or surgery.

Hematyle is generally well tolerated. Mild side effects may include gastrointestinal discomfort such as nausea, constipation, or dark stools due to iron. Rarely, hypersensitivity reactions to any component can occur. Excessive doses may lead to hypervitaminosis or iron overload if used without medical supervision in non-deficient individuals.

Hematyle Tablet is indicated for the prevention and treatment of iron deficiency anemia, megaloblastic anemia due to vitamin B12 and folate deficiency, nutritional anemia in pregnancy and lactation, and as a supportive supplement in chronic diseases associated with low hemoglobin or poor nutritional intake. It is also useful in patients with increased physiological demands, such as adolescence, post-surgery recovery, and during periods of rapid growth.

Hematyle should be used under medical guidance, especially in individuals with iron overload disorders such as hemochromatosis or hemosiderosis. It is safe in pregnancy and lactation when taken as recommended. Patients with a history of vitamin B12 deficiency should continue therapy for the full prescribed course to avoid neurological complications. Avoid taking high-dose antacids or calcium supplements simultaneously with iron, as they can reduce absorption. In case of accidental overdose, especially in children, seek immediate medical attention due to the risk of iron toxicity.

Store Hematyle Tablet in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep it in the original packaging and out of the reach of children. Do not use after the expiry date printed on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ferrous Asparto Glycinate + Methylcobalamin + L-Methylfolate Calcium Tablet in the PCD pharma franchise market?

This advanced hematinic and nutritional tablet formulation is used for iron deficiency anemia, vitamin B12 deficiency, neuropathy support, and nutritional supplementation, making it a high-demand product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this hematinic tablet in their product range?

Medical distributors and wholesalers can benefit from consistent demand in anemia management, pregnancy care, fatigue, neuropathy support, post-illness recovery, and nutritional deficiencies. The combination of ferrous asparto glycinate, methylcobalamin, and L-methylfolate calcium supports healthy red blood cell formation, nerve health, and improved nutrient absorption.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Ferrous Asparto Glycinate + Methylcobalamin + L-Methylfolate Calcium Tablet with monopoly rights, quality nutraceutical formulations, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this nutritional product?

Wholesalers and medical agencies benefit from strong repeat demand, stable prescription movement in gynecology and general medicine segments, and year-round nutritional supplement sales when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this hematinic tablet?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this nutritional formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.